Literature DB >> 33212171

A supercritical fluid technology for liposome production and comparison with the film hydration method.

Noémie Penoy1, Bruno Grignard2, Brigitte Evrard1, Géraldine Piel3.   

Abstract

Liposomes were produced by an innovative method using supercritical carbon dioxide as a dispersing agent. A quality by design strategy was used to find optimal production conditions with specific parameters (lipid concentration, dispersion volume, agitation rate, temperature and pressure) allowing the production of liposomes with predicted physicochemical characteristics (particles size and PdI). Two conditions were determined with specific production parameters. It was shown that these two conditions allowed the production of liposomes of different compositions and that most of the liposome formulations had size and dispersity in accordance with the prediction values. The condition involving the higher lipid concentration showed a higher variability in terms of size and dispersity. However, this variability remained acceptable. This innovative supercritical method allowed the production of liposomes with physicochemical characteristics similar to those obtained by the conventional thin film hydration method. This new supercritical carbon dioxide method easily scalable in GMP conditions is a one-step production method contrarily to conventional methods which generally need an additional step as extrusion to homogenize the size of liposomes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dense gas methods; Drug delivery systems; Liposomes; Nanoparticles; PGSS; Quality by design; Supercritical fluids

Mesh:

Substances:

Year:  2020        PMID: 33212171     DOI: 10.1016/j.ijpharm.2020.120093

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

Review 1.  Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Authors:  Martha Sahylí Ortega Pijeira; Herlys Viltres; Jan Kozempel; Michal Sakmár; Martin Vlk; Derya İlem-Özdemir; Meliha Ekinci; Seshasai Srinivasan; Amin Reza Rajabzadeh; Eduardo Ricci-Junior; Luciana Magalhães Rebelo Alencar; Mohammed Al Qahtani; Ralph Santos-Oliveira
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-25

2.  Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin.

Authors:  Ming Yuan; Jiangxiu Niu; Qinghan Xiao; Huiyuan Ya; Yansong Zhang; Yanli Fan; Lingmei Li; Xueke Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.